MARINUS PHARMACEUTICALS, INC. Revenue
MARINUS PHARMACEUTICALS, INC. reported Revenue of $8.54 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2024-11-12
- MARINUS PHARMACEUTICALS, INC. revenues for the quarter ending 2024-09-30 was $8.54M, a 16.39% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. revenues for the quarter ending 2024-06-30 was $8.06M, a 32.48% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. revenues for the quarter ending 2024-03-31 was $7.68M, a 26.02% decline year-over-year.
- MARINUS PHARMACEUTICALS, INC. revenues for the quarter ending 2023-12-31 was $7.19M, a 0.39% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. revenues for fiscal 2023 was $30.99M, a 21.63% increase from fiscal 2022.
- MARINUS PHARMACEUTICALS, INC. revenues for fiscal 2022 was $25.48M, a 66.03% increase from fiscal 2021.
- MARINUS PHARMACEUTICALS, INC. revenues for fiscal 2021 was $15.35M, a 793.19% increase from fiscal 2020.
- MARINUS PHARMACEUTICALS, INC. revenues for fiscal 2020 was $1.72M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2024-09-30 | $8.54M 10-Q · filed 2024-11-12 | $16.60M derived: sum of 2 quarters · filed 2024-11-12 | $24.28M 10-Q · filed 2024-11-12 | $31.47M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $8.06M 10-Q · filed 2024-08-13 | $15.73M 10-Q · filed 2024-08-13 | $22.93M derived: sum of 3 quarters · filed 2024-08-13 | $30.26M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | $7.68M 10-Q · filed 2024-05-08 | $14.87M derived: sum of 2 quarters · filed 2024-05-08 | $22.21M derived: sum of 3 quarters · filed 2024-11-12 | $28.29M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $14.53M derived: sum of 2 quarters · filed 2024-11-12 | $20.61M derived: sum of 3 quarters · filed 2024-11-12 | $30.99M 10-K · filed 2024-03-05 |
| 2023-09-30 | $7.34M 10-Q · filed 2024-11-12 | $13.42M derived: sum of 2 quarters · filed 2024-11-12 | $23.80M 10-Q · filed 2024-11-12 | $30.96M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $6.08M 10-Q · filed 2024-08-13 | $16.46M 10-Q · filed 2024-08-13 | $23.62M derived: sum of 3 quarters · filed 2024-08-13 | $25.96M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $10.38M 10-Q · filed 2024-05-08 | $17.54M derived: sum of 2 quarters · filed 2024-05-08 | $19.88M derived: sum of 3 quarters · filed 2024-05-08 | $21.67M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $9.50M derived: sum of 2 quarters · filed 2024-03-05 | $11.29M derived: sum of 3 quarters · filed 2024-03-05 | $25.48M 10-K · filed 2024-03-05 |
| 2022-09-30 | $2.34M 10-Q · filed 2023-11-07 | $4.13M derived: sum of 2 quarters · filed 2023-11-07 | $18.32M 10-Q · filed 2023-11-07 | $19.84M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.79M 10-Q · filed 2023-08-10 | $15.98M 10-Q · filed 2023-08-10 | $17.50M derived: sum of 3 quarters · filed 2023-08-10 | $27.61M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $14.19M 10-Q · filed 2023-05-11 | $15.71M derived: sum of 2 quarters · filed 2023-05-11 | $25.82M derived: sum of 3 quarters · filed 2023-05-11 | $27.73M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $11.63M derived: sum of 2 quarters · filed 2023-03-09 | $13.54M derived: sum of 3 quarters · filed 2023-03-09 | $15.35M 10-K · filed 2023-03-09 |
| 2021-09-30 | $10.11M 10-Q · filed 2022-11-07 | $12.02M derived: sum of 2 quarters · filed 2022-11-07 | $13.82M 10-Q · filed 2022-11-07 | $15.37M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $1.91M 10-Q · filed 2022-08-11 | $3.71M 10-Q · filed 2022-08-11 | $5.26M derived: sum of 3 quarters · filed 2022-08-11 | $5.43M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.81M 10-Q · filed 2022-05-12 | $3.35M derived: sum of 2 quarters · filed 2022-05-12 | $3.52M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.72M derived: sum of 2 quarters · filed 2022-03-24 | $1.72M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $171.00K 10-Q · filed 2021-11-09 | $171.00K 10-Q · filed 2021-11-09 | ||
| 2016-12-31 | $0.00 10-K · filed 2017-03-13 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $0.00 10-K · filed 2016-03-07 | ||
| 2015-09-30 | $0.00 10-Q · filed 2015-10-29 |